Long-term outcome of Tako-tsubo cardiomyopathy

Costin N Ionescu1, Cesar A Aguilar-Lopez, Antoine E Sakr

  • 1Section of Cardiology, Hospital of Saint Raphael, New Haven, Connecticut 06511, United States. cionescu@srhs.org

Insights

Tako-tsubo cardiomyopathy (TC) outcomes are worse than previously thought, with over half of patients experiencing adverse events. Myocardial perfusion grade does not predict outcomes in TC patients.

Area of Science:

  • Cardiology
  • Cardiovascular Research

Background:

  • Tako-tsubo cardiomyopathy (TC) is often associated with an excellent patient outcome.
  • However, recent findings suggest a need to re-evaluate the long-term prognosis of TC.

Purpose of the Study:

  • To assess the long-term outcome of patients diagnosed with TC.
  • To determine the prognostic significance of thrombolysis in myocardial infarction myocardial perfusion grade (TMPG) in TC patients.

Main Methods:

  • A retrospective analysis was conducted on all patients diagnosed with TC between 2003 and 2008.
  • Data from 27 TC patients were analyzed, with a mean follow-up of 27 months.

Main Results:

  • Over half of TC patients (52%) experienced a combined endpoint including death, cardiogenic shock, sudden cardiac death, or cardiac rehospitalization.
  • Abnormal TMPG was observed in 37% of cases, but it did not correlate with patient outcomes.
  • The study population predominantly consisted of postmenopausal Caucasian females (96%).

Conclusions:

  • The long-term outcome for patients with TC is poorer than previously reported.
  • TMPG is not a reliable predictor of outcomes in patients with TC.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...